18135-30-3 Usage
Uses
Used in Organic Synthesis:
2-(trimethylsilyl)ethanamine hydrochloride is used as a reagent for the modification of biomolecules and pharmaceuticals, providing a protective function for functional groups during chemical reactions.
Used in Chemical Reactions:
2-(trimethylsilyl)ethanamine hydrochloride is used as a facilitator for the formation of amide and ester linkages, enhancing the efficiency and selectivity of these reactions.
Used in Drug Development:
2-(trimethylsilyl)ethanamine hydrochloride is utilized in the development of new drugs, contributing to the advancement of pharmaceutical research and the creation of innovative therapeutic agents.
Used in the Preparation of Siloxane-based Materials:
In the field of material science, 2-(trimethylsilyl)ethanamine hydrochloride is used as a precursor in the preparation of siloxane-based materials, which have applications in various industries due to their unique properties.
Used in Chemistry Research:
As a versatile chemical compound, 2-(trimethylsilyl)ethanamine hydrochloride is employed in chemistry research to explore new reaction pathways and develop novel synthetic methods.
Used in Biochemistry Research:
In biochemistry, 2-(trimethylsilyl)ethanamine hydrochloride is used to study the interactions of biomolecules and to develop methods for the modification of biologically active compounds, contributing to a deeper understanding of biological processes and the development of bioactive molecules.
Check Digit Verification of cas no
The CAS Registry Mumber 18135-30-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,8,1,3 and 5 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 18135-30:
(7*1)+(6*8)+(5*1)+(4*3)+(3*5)+(2*3)+(1*0)=93
93 % 10 = 3
So 18135-30-3 is a valid CAS Registry Number.
InChI:InChI=1/C5H15NSi.ClH/c1-7(2,3)5-4-6;/h4-6H2,1-3H3;1H
18135-30-3Relevant academic research and scientific papers
Kinase inhibitory compound and medical use thereof
-
Paragraph 0128; 0131, (2018/09/08)
A kinase inhibitory compound and medical use thereof are disclosed. The present invention provides the kinase inhibitory compound shown as formula (I), a stereoisomer, a tautomer or a pharmaceuticallyacceptable salt thereof, and the use thereof as a FGFR4 kinase selective inhibitor in preparation of a drug or a drug composition for treatment of diseases caused by FGFR4 or FGF19. The compound hasselective significant inhibitory activity against the FGFR4, and has broad application prospects in the field of tumor treatment.
